SJ-3366 is primarily utilized in the field of antiviral research, particularly in the study of HIV. It functions as a potent and selective inhibitor of HIV-1 integrase, an enzyme crucial for the viral replication process. By blocking this enzyme, SJ-3366 effectively prevents the integration of viral DNA into the host genome, thereby halting the progression of the infection. This makes it a valuable compound in the development of antiretroviral therapies aimed at managing and potentially treating HIV/AIDS. Additionally, its specificity and efficacy have sparked interest in further exploring its potential in combating other retroviral infections. Research is ongoing to optimize its pharmacological properties and assess its safety profile for potential clinical use.